|
|
20202 Windrow Drive
Lake Forest, CA 92630 USA
phone:(949) 206-2700
fax:(949) 206-2600
|
|
| Symbol |
IFLO |
| Exchange |
Nasdaq |
| Founded |
1985 |
| Employees |
810 |
|
|
| www.iflo.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Ambulatory drug delivery systems for pain management and intravenous infusion therapy. |
|
| Management |
| Donald M. Earhart, President & CEO; James R. Talevich, CFO; James J. Dal Porto, Exec. VP and COO |
| |
|
|
|
|
|
|
|
| Keywords |
| ambulatory drug delivery, pain, pain management, infusion therapy, anesthetics, anesthesia, chemotherapies, antibiotics, diagnostic agents, nutritional supplements, oncology, cancer, orthopedics, urology
, PainManagement, DrugDelivery |
|
|
|
|
|
|
| Description |
|
I-Flow develops and markets ambulatory drug delivery systems for pain management and intravenous infusion therapy. The company focuses on three distinct markets: Regional Anesthesia, IV Infusion Therapy and Oncology Infusion Services. |
|
| Products / Services |
|
I-Flow manufactures a line of compact, portable infusion pumps, catheters, needles and pain kits that administer medication directly to the wound site, as well as administer local anesthetics, chemoth...
view more
|
|
| Technology / Differentiation |
| The ON-Q PainBuster Post-Op Pain Relief System provides continuous infusion of a local anesthetic directly into the patient's surgical site for effective, non-narcotic post-operative pain relief for up to five days. Clinical studies have demonstrated the safety and efficacy of regional anesthetic therapy for post-surgery pain relief. |
|
| Market / Customers |
|
The annual U.S. post-surgery pain relief market is estimated at $2 billion. This market is about 4% penetrated by narcotic-free regional anethesia therapies. I-Flow estimates that 15 million U.S. surg...
view more
|
|
| Competitors / Substitutes / Alternatives |
Narcotics remain I-Flow's chief competitor in the relief of post-surgical pain. About 96% of U.S. patients are treated with narcotics for post-operative pain. Other companies with narcotic-free therapies include Stryker, dj Orthopedics and McKinley Medical.
|
|
| Strategy |
I-Flow is focused on building market awareness of the clinical and economic advantages of ON-Q technology through a combination of clinical studies, sales force expansion and marketing programs.
|
|
| Analyst Coverage |
| First Albany Corp., Lazard Freres & Co., Jefferies & Co., Piper Jaffray, Roth Capital Partners, SG Cowen & Co., Sidoti & Company; WR Hambrecht; B. Riley |
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members